All Collections
Assessment Library
Assessments
Yale PRIME Early Psychosis Screening Test (Yale-PRIME)
Yale PRIME Early Psychosis Screening Test (Yale-PRIME)
Mona Barman avatar
Written by Mona Barman
Updated over a week ago

Brief Description

The Yale PRIME Early Psychosis Screening Test (Yale-PRIME) assesses an individual's risk of developing a psychotic disorder. The Yale-PRIME looks at "prodromal" symptoms of psychosis: symptoms that often occur before a full-blown psychosis clinical presentation. The PRIME screening test was developed based on a structured interview known as the SIPS (Structured Interview for Prodromal Syndromes). Respondents rate how much they related to the symptoms listed (e.g., “I think that I have felt that there are odd or unusual things going on that I can’t explain”) on a scale from “Definitely disagree” to “Definitely agree.”


Assessment Administration Type

Self-report


Number of questions

12


Age Range for Administration

18+


Recommended Frequency of Administration

One time screener


Summary of Scoring and Interpretations

The Yale-PRIME contains 12 questions scored on a 7-point Likert scale with values from 0 ("Definitely disagree") to 6 ("Definitely agree"). A positive screen can be either one or more scores of "6" or three or more scores of "5." Note: a positive screen does not confirm a diagnosis and further evaluation is recommended.

Score

Interpretation

6 on any question

Positive screening result; consider further assessment.

5 on three or more questions

Positive screening result; consider further assessment.


Blueprint Adjustments

Blueprint provides a total score that consists of summing all questions, with higher scores indicating greater prodromal psychotic experiences. However, clinicians may review the assessment results and examine each question’s response to determine if it’s a positive screen using the scoring criteria above.


Clinical Considerations

  • 3-5 minutes to complete

  • Research on the Yale-PRIME is limited because it is based on the structured interview, the Structural Interview for Prodromal Symptoms.

  • As noted, a positive screening does not equate to a diagnosis and further diagnostic evaluation is recommended.


Citation


Relevant Articles + Further Resources


We're here for you!

Do you have follow-up questions? We're here and happy to help!

Send us an email at help@blueprint-health.com or use the help messenger in the lower right corner to speak with our Support team. 💪🏼

Did this answer your question?